MERIS LABORATORIES INC
SC 13D/A, 1997-03-06
MEDICAL LABORATORIES
Previous: VERTEX PHARMACEUTICALS INC / MA, S-3MEF, 1997-03-06
Next: MERIS LABORATORIES INC, SC 13D, 1997-03-06



                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  SCHEDULE 13D

                   Under the Securities Exchange Act of 1934
                                (Amendment No.1)


                             MERIS LABORATORIES, INC.
- - ----------------------------------------------------------------------------
                                (Name of Issuer)

                                  Common Stock
- - ----------------------------------------------------------------------------
                         (Title of Class of Securities)

                                   589848100
- - ----------------------------------------------------------------------------
                                 (CUSIP Number)

                               Stephen Feinberg
                               450 Park Avenue
                                  28th Floor
                            New York, New York 10022
                                (212) 891-2100
- - ----------------------------------------------------------------------------
            (Name, Address and Telephone Number of Person Authorized
                     to Receive Notices and Communications)

                               November 18, 1996
- - ----------------------------------------------------------------------------
             (Date of Event which Requires Filing of this Statement)

     If the filing person has previously filed a statement on Schedule 13G
to report the acquisition which is the subject of this Schedule 13D, and
is filing this schedule because of Rule 13d-1(b)(3) or (4), check the
following box.     [ ]

                                  Page 1 of 6 Pages
<PAGE>
____________________________________________________________________________ 
(1)  NAME OF REPORTING PERSON
          S.S. OR I.R.S. IDENTIFICATION NO.
          OF ABOVE PERSON
            Stephen Feinberg
_____________________________________________________________________________
     (2)  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
                                                                    (a)  [ ]
                                                                    (b)  [x]
_____________________________________________________________________________
     (3)  SEC USE ONLY
_____________________________________________________________________________
     (4)  SOURCE OF FUNDS
            WC
_____________________________________________________________________________
     (5)  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
          TO ITEM 2(d) OR 2(e)                                        [ ]
_____________________________________________________________________________
     (6)  CITIZENSHIP OR PLACE OF ORGANIZATION
            United States
_____________________________________________________________________________

NUMBER OF      (7)  SOLE VOTING POWER*
                        
SHARES         ______________________________________________________________

BENEFICIALLY   (8)  SHARED VOTING POWER*
                        
OWNED BY       ______________________________________________________________


EACH           (9)  SOLE DISPOSITIVE POWER*
                        
REPORTING      ______________________________________________________________

PERSON WITH    (10)  SHARED DISPOSITIVE POWER*
                        
_____________________________________________________________________________
     (11)  AGGREGATE AMOUNT BENEFICIALLY OWNED
          BY EACH REPORTING PERSON
            1,676,058
_____________________________________________________________________________
    (12)  CHECK BOX IF THE AGGREGATE AMOUNT
          IN ROW (11) EXCLUDES CERTAIN SHARES **                          [ ]
_____________________________________________________________________________
    (13)  PERCENT OF CLASS REPRESENTED
          BY AMOUNT IN ROW (11)
            17.30%
_____________________________________________________________________________
    (14)  TYPE OF REPORTING PERSON **
            IN
_____________________________________________________________________________
                    ** SEE INSTRUCTIONS BEFORE FILLING OUT

- ------------------------------------

*    (a)  The person filing this statement is Stephen Feinberg.  Mr. Feinberg 
indirectly through one or more partnerships or other entities, possesses 
voting and investment power over all Shares owned by (i) Cerberus Partners, 
L.P. ("Cerberus"), a Delaware limited partnership, (ii) Cerberus 
International, Ltd. ("International") and Ultra Cerberus Fund, Ltd. ("Ultra"), 
each of which are corporations organized under the laws of the Bahamas, and 
(iii) various private investment funds (the "Funds").

     (b)  The approximate aggregate percentage of securities reported 
beneficially owned by each person herein is based on 792,000 Shares underlying 
Warrants and 884,058 Shares underlying Debentures (assuming a conversion price 
of $3.45 per Share). 
     (c)  Although Cerberus is the record owner of all of the principal amount 
of the Debentures issued pursuant to the Purchase (as defined in Item 3), and 
Madeleine LLC ("Madeleine") is the record owner of all of the Warrants issued 
pursuant to the Loan Agreement (as defined in Item 3), pursuant to 
participation agreements with Cerberus or Madeleine, as the case may be, as of 
the date hereof, (i) Cerberus is the beneficial owner of 200,000 Warrants and 
$750,000 in principal amount of Debentures, (ii) International is the 
beneficial owner of 200,000 Warrants and $750,000 in principal amount of 
Debentures, (iii) Ultra is the beneficial owner of 24,000 Warrants and 
$150,000 in principal amount of Debentures and (iv) the Funds are the 
beneficial owners of 368,000 Warrants and $1,400,000 in principal amount of 
Debentures.  The remaining Warrants and Debentures were transferred to 
entities over which Stephen Feinberg possesses no voting or investment power.  
The transactions were private transactions.  Madeleine disclaims beneficial 
ownership of the Warrants although it is the record holder of such Warrants.

                               Page 2 of 6 Pages
<PAGE>
ITEM 1.  SECURITY AND ISSUER.

This Amendment No. 1 (the "Amendment") amends the Statement on Schedule 13D 
dated November 29, 1996 (the "13D") filed by Madeleine LLC ("Madeleine"), 
Cerberus Partners, L.P. ("Cerberus") and Stephen Feinberg and others with 
respect to shares of Common Stock, par value $0.01 per share ("Shares") 
underlying certain warrants ("Warrants") and 10% Convertible Senior 
Subordinated Debentures ("Debentures") of Meris Laboratories, Inc. (the 
"Company") whose principal executive offices are located at 2890 Canker Road, 
San Jose, California 95134.  Certain terms used and not described in this 
Amendment have the meanings ascribed to them in the 13D.

ITEM 2.   IDENTITY AND BACKGROUND.

Item 2 as reported in the 13D is hereby amended and restated as follows:

(a)   The person filing this statement is Stephen Feinberg.  Mr. Feinberg 
indirectly through one or more partnerships or other entities, possesses 
voting and investment power over all Shares owned by (a) Cerberus (b) Cerberus 
International, Ltd. ("International") and Ultra Cerberus Fund, Ltd. ("Ultra") 
each of which are corporations organized under the laws of the Bahamas, and 
(c) various private investment funds (the "Funds").  Cerberus, International, 
Ultra and the Funds are engaged in the investment in personal property of all 
kinds, including, but not limited to, capital stock, depository receipts, 
investment companies, mutual funds, subscriptions, warrants, bonds, notes, 
debentures, options and other securities of whatever kind and nature.

(b)   The address of the principal place of business and principal office of 
Stephen Feinberg is 450 Park Avenue, New York, New York, 10022.

(c)   The principal occupation of Stephen Feinberg is as the General Partner 
of Feinberg Management L.P. and other related investment firms.

(d)   Stephen Feinberg has not, during the last five years, been convicted in 
a criminal proceeding (excluding traffic violations or similar misdemeanors).

(e)   Stephen Feinberg has not, during the last five years, been a party to a 
civil proceeding of a judicial or administrative body of competent 
jurisdiction and as a result of such proceeding been subject to a judgment, 
decree or final order enjoiningfuture violations of, or prohibiting or 
mandating activities subject to,Federal or state securities laws or finding 
any violation with respect to suchlaws.

(f)   Stephen Feinberg is a citizen of the United States.


                               Page 3 of 6 Pages
<PAGE>
ITEM 3.   SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

Item 3 as reported in the 13D is hereby amended and restated as follows:

On November 18, 1996, Madeleine, as lender and the Company, as borrower, 
entered into a demand loan agreement (the "Loan Agreement") pursuant to which 
a portion of Meris' consideration therefor consisted of Warrants for the 
purchase of 800,000 Shares.  Prior to that, on September 30, 1996, Cerberus 
purchased (the "Purchase") $3,150,000 in principal amount of Debentures 
previously issued by the Company.  The Debentures, if not redeemed, are 
convertible to common stock.  The current conversion price under the 
Debentures when purchased by Cerberus was $3.45 per Share.

All funds used to purchase such Debentures and Warrants of the Company on 
behalf of Cerberus, International, Ultra and the Funds came directly from the 
net assets of such entities.

ITEM 4.   PURPOSE OF THE TRANSACTION.

Item 4 as reported in the 13D is hereby amended and restated as follows:

The purpose of the acquisition of the Warrants and Debentures on behalf of 
Cerberus, International, Ultra and the Funds is for investment.

Other than as set forth above, Stephen Feinberg does not have anyplans or 
proposals which relate to, or could result in, any of the mattersreferred to 
in paragraphs (b) through (j), inclusive, of Item 4 of Schedule13D.  Such 
entities and persons may, at any time and from time to time,review or 
reconsider their position with respect to any of such matters, but have no 
present intention of doing so.

ITEM 5.   INTEREST IN SECURITIES OF THE ISSUER.

Item 5 as reported in the 13D is hereby amended and restated as follows:

(a)   The approximate aggregate percentage of Securities reported beneficially 
owned by the reporting person herein is based on 9,686,593 Shares including 
8,010,535 Shares outstanding as of September 16, 1996, as reflected in the 
Form 10Q of the Company for the period ending September 30, 1996 plus 792,000 
Shares underlying Warrants beneficially owned by the reporting person, plus 
884,058 Shares underlying Debentures beneficially owned by the reporting 
person (assuming a conversion price of $3.45 per Share).  For purposes of 
calculating the percentages herein, the number of Shares underlying Warrants 
and Debentures beneficially owned by the reporting person has been added to 
the number of Shares outstanding as though such Warrants had been exercised 
and such Debentures had been converted.

      Although Cerberus is the record owner of all of the principal amount of 
Debentures issued pursuant to the Purchase, and Madeleine is the record owner 
of all Warrants issued pursuant to the Loan Agreement, pursuant to 
participation agreements with Cerberus or Madeleine, as the case may be, as of 
the date hereof, (i) Cerberus is the beneficial owner of 200,000 Warrants and 
$750,000 in principal amount of the Debentures, (ii) International is the 
beneficial owner of 200,000 Warrants and $750,000 in principal amount of the 
Debentures, (iii) Ultra is the beneficial owner of 24,000 Warrants and 
$150,000 in principal amount of the Debentures and (iv) the Funds are the 
beneficial owners of 368,000 Warrants and $1,400,000 in principal amount of 
Debentures.  The remaining Warrants and Debentures were transferred to 
entities over which Stephen Feinberg possesses no voting or investment power.  
The transactions were private transactions.  Madeleine disclaims beneficial 
ownership of the Warrants although it is the record holder of such Warrants.

(b)   Stephen Feinberg possesses voting and investment power over all Shares 
owned by Cerberus, International, Ultra and the Funds.


                               Page 4 of 6 Pages
<PAGE>



Stephen Feinberg owns directly no Shares.  By reason of the provisions of Rule 
13d-3 of the Act, Stephen Feinberg may be deemed to own beneficially 792,000 
Warrants and Debentures convertible into 884,058 Shares, constituting 
approximately 17.30% of the Shares outstanding.  Madeleine disclaims 
beneficial ownership of the Shares held.

(c)   On September 30, 1996 Cerberus purchased Debentures which are 
convertible into 913,043 Shares (assuming a conversion price of $3.45 per 
share, which was the conversion price in effect at the time the Company issued 
the Debentures), and on November 18, 1996, the Company issued to Madeleine 
Warrants to purchase 800,000 Shares at $0.01 per share.  Pursuant to 
participation agreements, Cerberus, International, Ultra and the Funds became 
beneficial owners of the Warrants and Debentures as described above.  Certain 
of the Warrants and Debentures issued to Madeleine and Cerberus were 
transferred to entities over which Stephen Feinberg possesses no voting or 
investment power.  The transactions were private transactions.

ITEM 6.  CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
TO SECURITIES OF THE ISSUER

Item 6 as reported in the 13D is hereby amended and restated as follows:

Other than as described above, there are no contracts, understandings or 
relationships (legal or otherwise) among the persons named in Item 2 hereof 
and between such persons or any person with respect to any securities of the 
Company, including but not limited to transfer or voting of any of the Shares, 
finder's fees, joint ventures, loan or option arrangements, puts or calls, 
guarantees of profits, division of profits or loss, or the giving or 
withholding of proxies.

ITEM 7.  MATERIAL TO BE FILED AS EXHIBITS

Not Applicable.



                               Page 5 of 6 Pages
<PAGE>





After reasonable inquiry and to the best of their knowledge and belief, the 
undersigned certify that the information set forth in this statement is true, 
complete and correct.



                                    March 6, 1997



                                    /s/ STEPHEN FEINBERG
                                    Stephen Feinberg, on
                                    behalf of 
                                    Cerberus Partners, L.P.,
                                    Cerberus International, Ltd.,
                                    Ultra Cerberus Fund, Ltd.,
                                    Madeleine LLC and the various
                                    private investment funds.





                               Page 6 of 6 Pages



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission